A decrease in spatially resolved near-infrared spectroscopy-determined frontal lobe tissue oxygenation by phenylephrine reflects reduced skin blood flow. Ogoh S, Sato K, Okazaki K, Miyamoto T, Secher F, Sørensen H, Rasm

First Page		Document Content
Date: 2014-10-30 11:45:12 Medical tests Stroke Neurotrauma Transcranial Doppler Phenylephrine Pulse oximetry Vasoconstriction Carotid endarterectomy Cerebral blood flow Medicine Neurology Cardiovascular physiology		A decrease in spatially resolved near-infrared spectroscopy-determined frontal lobe tissue oxygenation by phenylephrine reflects reduced skin blood flow. Ogoh S, Sato K, Okazaki K, Miyamoto T, Secher F, Sørensen H, Rasm Add to Reading List Source URL: www2.snacc.org Download Document from Source Website File Size: 330,28 KB Share Document on Facebook

	In D. Reitter & F. E. Ritter (Eds.), Proceedings of the 14th International Conference on Cognitive Modeling (ICCMUniversity Park, PA: Penn State. Effects of Guanfacine and Phenylephrine on a Spiking Neuron Model DocID: 1uIFb - View Document
	PROGRAMME DE SURVEILLANCE* 2016 Les substances ci-dessous sont incluses dans le programme de surveillance 2016 : 1. Stimulants : En compétition seulement : Bupropion, caféine, nicotine, phényléphrine, phénylpropanol DocID: 1qrJn - View Document
	Official Newsletter of the Utah Poison Control Center 2008 • Volume 10 • Issue 1 The University of Utah Utah Poison Control Center DocID: 1oyfz - View Document
	THE 2016 MONITORING PROGRAM* The following substances are placed on the 2016 Monitoring Program: 1. Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and syneph DocID: 1nNeY - View Document
	THE 2016 MONITORING PROGRAM* The following substances are placed on the 2016 Monitoring Program: 1. Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and syneph DocID: 1ne21 - View Document